• Inotiv, Inc. to Participate in Upcoming Investor Conferences

    ソース: Nasdaq GlobeNewswire / 01 11 2023 08:00:01   America/New_York

    WEST LAFAYETTE, Ind., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will participate in multiple upcoming investor conferences throughout November 2023.

    Event: Jefferies London Healthcare Conference
    Location: London, United Kingdom
    Presentation Date: November 15, 2023
    Time: 4:00 PM Greenwich Mean Time

    Event: 14th Annual Craig-Hallum Alpha Select Conference
    Location: New York, NY
    Date: November 16, 2023

    Event: 6th Annual Evercore ISI HealthCONx Conference
    Location: Miami, FL
    Presentation Date: November 29, 2023
    Time: 3:00 PM Eastern Time
    Link to Webcast

    The webcast presentations will be available for viewing and replay under the “Investor Relations” tab of the Company's website at www.inotivco.com.    

    About Inotiv

    Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotivco.com/

    Company ContactInvestor Relations
    Inotiv, Inc.LifeSci Advisors
    Beth A. Taylor, Chief Financial OfficerBob Yedid
    (765) 497-8381(516) 428-8577
    btaylor@inotivco.combob@lifescieadvisors.com
      


    Primary Logo

シェアする